Last kr19.00 SEK
Change Today 0.00 / 0.00%
Volume 3.2K
HMED On Other Exchanges
Symbol
Exchange
Stockholm
As of 12:00 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

hansa medical research ab (HMED) Snapshot

Open
kr18.60
Previous Close
kr19.00
Day High
kr19.00
Day Low
kr18.60
52 Week High
01/27/14 - kr19.65
52 Week Low
08/26/13 - kr3.44
Market Cap
492.7M
Average Volume 10 Days
5.2K
EPS TTM
kr-0.78
Shares Outstanding
25.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HANSA MEDICAL RESEARCH AB (HMED)

Related News

No related news articles were found.

hansa medical research ab (HMED) Related Businessweek News

No Related Businessweek News Found

hansa medical research ab (HMED) Details

Hansa Medical AB operates as a biotechnology research and development company that focuses on the treatment and diagnosis of inflammation. The company is developing IdeS, an enzyme based drug candidate that is in a clinical Phase I trials for the treatment of sensitized kidney transplantation patients prior to the transplantation; and EndoS, an enzyme, which is in preclinical discovery phase for therapeutic applications in rare autoimmune diseases. It also develops HMD-301, a diagnostic assay for the diagnosis and prognosis of severe sepsis. The company has collaboration agreement with Axis-Shield plc to develop and commercialize heparin binding protein as a biomarker for severe sepsis. Hansa Medical AB was founded in 2001 and is based in Lund, Sweden.

Founded in 2001

hansa medical research ab (HMED) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hansa medical research ab (HMED) Key Developments

Hansa Medical AB Presents at BIO International Convention, Jun-26-2014 10:15 AM

Hansa Medical AB Presents at BIO International Convention, Jun-26-2014 10:15 AM. Venue: San Diego Convention Center, San Diego, California, United States.

Hansa Medical AB Reports Group Earnings Results for the Year 2013

Hansa Medical AB reported group earnings results for the year 2013. For the year, the company's net sales were SEK 1.8 million against SEK 2.6 million a year ago. Loss was SEK 17.6 million against SEK 16.5 million a year ago. Operating loss was SEK 17.6 million against SEK 16.8 million a year ago. Loss per share was SEK 0.79 million against SEK 0.78 million a year ago.

Hansa Medical AB Presents at 8th Annual BIO Europe Spring 2014, Mar-11-2014 10:15 AM

Hansa Medical AB Presents at 8th Annual BIO Europe Spring 2014, Mar-11-2014 10:15 AM. Venue: OVAL Lingotto, Turin, Italy.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HMED:SS kr19.00 SEK 0.00

HMED Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HMED.
View Industry Companies
 

Industry Analysis

HMED

Industry Average

Valuation HMED Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 221.7x
Price/Book 8.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 258.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANSA MEDICAL RESEARCH AB, please visit www.hansamedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.